Validation of commercially available antibodies directed against subunits of the epithelial Na+ channel is a research paper published in Physiological Reports (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: P30 DK079307
Foundation for the National Institutes of Health
Grant: R01 DK130901
Foundation for the National Institutes of Health
Grant: R01 HL128053
Foundation for the National Institutes of Health
Grant: R01 HL147818
Foundation for the National Institutes of Health
Grant: T32 DK007052
Foundation for the National Institutes of Health
Grant: T32 DK061296
NIDDK NIH HHS
Grant: R03 DK119752
NIDDK NIH HHS
Grant: R01 DK129285
FWCI
1.40
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords